Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis

Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system and a leading cause of neurological disability. The complex immunopathology and variable disease course of multiple sclerosis have limited effective treatment of all patients. Altering the metabolism of immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Shriver, Leah P., Manchester, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216566/
https://www.ncbi.nlm.nih.gov/pubmed/22355598
http://dx.doi.org/10.1038/srep00079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216566/
https://www.ncbi.nlm.nih.gov/pubmed/22355598
http://dx.doi.org/10.1038/srep00079

Ejemplares similares